Moxifloxacin Hydrochloride Tablet, Film Coated
Product Images NDC 71335-2329

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Moxifloxacin Hydrochloride (NDC 71335-2329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352329)

Label for Moxifloxacin Tablets, USP 400 mg film-coated oral tablets. The package contains 7 tablets. Repackaged by Bryant Ranch Prepack, Inc., Burbank, CA. Manufactured by Aurobindo Pharma Limited. Features NDC 71335-2329-1, barcode, and storage instructions to keep at 20° to 25°C and avoid excessive humidity.*

FDA Label Image

Figure 1 (Moxifloxacin Fig1)

A pharmacokinetic graph showing plasma concentration (mcg/mL) over time (hours) comparing oral dose and intravenous dose of moxifloxacin hydrochloride. The graph illustrates the concentration peak and decline for both administration routes within 24 hours.*

FDA Label Image

Structure (Moxifloxacin Str)

Chemical structure of moxifloxacin hydrochloride, showing the molecular arrangement with fluorine, oxygen, nitrogen, and carbon atoms including the hydrochloride moiety. The structure highlights the core quinolone framework with substituents relevant to its activity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.